Farms.com Home   News

Wet Fall Means Increased Risk Of White Mould

Altona and Portage hosted meetings for edible bean growers last week.
 
David Kaminski, field crop pathologist with Manitoba Agriculture & Resource Development, talked about the risk of white mould appearing this year in dry beans.
 
"Last year we had a wet fall. There are opportunities for sclerotinia to multiply in a field in those conditions even if it didn't cause disease that resulted in yield loss," he commented. "We had the conditions last fall which set up for leaving behind a lot of the resting bodies and if its wet in the spring then we can ultimately be at risk from white mould again."
 
Kaminski says the last three years have been relatively free of white mould in dry beans.
 
He notes management strategies are complex, adding rotation is not useful because white mould can affect multiple crop types. A key component is knowing where those resting bodies are located and then applying fungicide at the appropriate time.
Click here to see more...

Trending Video

Finding a Balance of Innovation and Regulation - Dr. Peter Facchini

Video: Finding a Balance of Innovation and Regulation - Dr. Peter Facchini

Regulations help markets and industry exist on level playing fields, keeping consumers safe and innovation from going too far. However, incredibly strict regulations can stunt innovation and cause entire industries to wither away. Dr. Peter James Facchini brings his perspective on how existing regulations have slowed the advancement of medical developments within Canada. Given the international concern of opium poppy’s illicit potential, Health Canada must abide by this global policy. But with modern technology pushing the development of many pharmaceuticals to being grown via fermentation, is it time to reconsider the rules?

Dr. Peter James Facchini leads research into the metabolic biochemistry in opium poppy at the University of Calgary. For more than 30 years, his work has contributed to the increased availability of benzylisoquinoline alkaloid biosynthetic genes to assist in the creation of morphine for pharmaceutical use. Dr. Facchini completed his B.Sc. and Ph.D. in Biological Sciences at the University of Toronto before completing Postdoctoral Fellowships in Biochemistry at the University of Kentucky in 1992 & Université de Montréal in 1995.